Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers.
Muhammad BilalSami UllahUlrich JaehdeChristina TrueckDario ZarembaBertil WachallManfred WargenauBernhard ScheidelMartin H J WiesenMalaz GazzazChunli ChenSören BüskerUwe FuhrMax TaubertCharalambos DokosPublished in: European journal of clinical pharmacology (2024)
Our results indicate that beyond BW, body composition as reflected by FFM could also be relevant for optimized dosing of rifampicin. This assumption needs to be studied further in patients treated with rifampicin.